15-Deoxy-δ12,14-prostaglandin J2 inhibits IL-1β-induced cyclooxygenase-2 expression in mesangial cells

Kidney International

Volumn 61, Issue 6, 2002, Pages 1957-1967

  Sawano, Hirotaka ^a   Haneda, Masakazu ^a   Sugimoto, Toshiro ^a   Inoki, Ken ^a   Koya, Daisuke ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

15d PGJ2; Activator protein 1; Anti inflammatory; COX 2; Glomerular mesangial cells; Mitogen activated protein kinases

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOTRANSFERASE; PROSTAGLANDIN E2; PROTEIN C JUN; THIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR AP 1; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; CELL RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; DNA; DRUG DERIVATIVE; INTERLEUKIN 1; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROSTAGLANDIN D2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; GENETIC TRANSFECTION; IMMUNOBLOTTING; INCUBATION TIME; MALE; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN RELEASE; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; MESANGIUM; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DNA; GLOMERULAR MESANGIUM; INTERLEUKIN-1; ISOENZYMES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 0035983446     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00351.x     Document Type: Article

References (66)

1. Cell culture approaches to the analysis of glomerular inflammation
2. Cytokines and mesangial cells
3. Biologic basis for interleukin-1 in disease
4. Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells
5. Interleukin 1 beta and tumor necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells
6. Arachidonic acid metabolism
7. Prostaglandin endoperoxide synthase: Structure and catalysis
8. Prostaglandin synthase 2
9. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids
10. Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells
11. Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1 beta
12. Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells
13. Differential regulation of COX-2 expression in the kidney by lipopolysaccharide: Role of CD 14
14. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells
15. Endothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells
16. Endothelin-1 induces cyclooxygenase-2 expression via nuclear factor of activated T-cell transcription factor in glomerular mesangial cells
17. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
18. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
19. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma
20. 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
21. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
22. COX-2 and the cyclopentenone prostaglandins - A new chapter in the book of inflammation?
23. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
24. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
25. Expression and function of PPARgamma in rat and human vascular smooth muscle cells
26. Expression peroxisome proliferator-activated receptor gamma in rat aortic smooth muscle cells
27. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12,14-prostaglandin J2
28. Feedback control of cyclooxygenase-2 expression through PPARgamma
29. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
30. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: Involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation
31. Cyclopentenone prostaglandins suppress activation of microglia: Down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2
32. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway
33. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase
34. Regulation of cyclooxygenase expression in the kidney by dietary salt intake
35. Evidence for existence of polyol pathway in cultured rat mesangial cells
36. Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation
37. The mouse homologue of the human acidic ribosomal phosphoprotein PO: A highly conserved polypeptide that is under translational control
38. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2
39. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta
40. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
41. p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta
42. Interleukin-1beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation
43. Interleukin-1 stimulates Jun N-terminal/stress-activated protein kinase by an arachidonate-dependent mechanism in mesangial cells
44. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p 38 MAPK signal pathways in rat renal mesangial cells
45. Activation of ternary complex factor Elk-1 by MAP kinases
46. Transcriptional regulation by extracellular signals: Mechanisms and specificity
47. The regulation of AP-1 activity by mitogen-activated protein kinases
48. Cyclooxygenase-2 in the kidney
49. Biological activities and mechanisms of action of PGJ2 and related compounds: An update
50. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: Correlation with induction of heme oxygenase 1
51. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: Evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression
52. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p 300
53. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation
54. Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells
55. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells
56. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists
57. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma
58. Cyclopentenone prostaglandins inhibit cytokine-induced NF-kappaB activation and chemokine production by human mesangial cells
59. MAPK signaling and the kidney
60. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions
61. Atrial natriuretic peptide inhibits endothelin-1-induced activation of mitogen-activated protein kinase in cultured rat mesangial cells
62. Atrial natriuretic peptide inhibits endothelin-1-induced activation of JNK in glomerular mes-angial cells
63. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation
64. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive Heymann nephritis in the rat
65. Different actions of the cyclooxygenase 2 selective inhibitor flosulide in rats with passive Heymann nephritis
66. A selective cyclooxygen-ase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats